Cited by 2,049Multiple Sclerosis Research StudiesViral-associated cancers and disordersCytomegalovirus and herpesvirus research

The DOI matches its Crossref record; 50 of the 51 references it cites were found in a registry or an index.

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Bjornevik, Kjetil, Cortese, Marianna, Healy, Brian C., Kuhle, Jens, Mina, Michael J., Leng, Yumei, Elledge, Stephen J., Niebuhr, David W., Scher, Ann I., Munger, Kassandra L., Ascherio, Alberto·2022·Science

DOI 10.1126/science.abj8222

Open this paper in CoChat — free account

Abstract

Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system of unknown etiology. We tested the hypothesis that MS is caused by Epstein-Barr virus (EBV) in a cohort comprising more than 10 million young adults on active duty in the US military, 955 of whom were diagnosed with MS during their period of service. Risk of MS increased 32-fold after infection with EBV but was not increased after infection with other viruses, including the similarly transmitted cytomegalovirus. Serum levels of neurofilament light chain, a biomarker of neuroaxonal degeneration, increased only after EBV seroconversion. These findings cannot be explained by any known risk factor for MS and suggest EBV as the leading cause of MS.

Integrity signals

Registry

Crossref · 10.1126/science.abj8222

Cites

50 of 50 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Sensitivity analysis in observational research: Introducing the E-value
VanderWeele, T. J., & Ding, P. (2017) · Annals of Internal Medicine · doi:10.7326/m16-2607 · Cited by 6,350
Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis
The International Multiple Sclerosis Genetics Consortium & The Wellcome Trust Case Control Consortium 2 (2011) · Nature · doi:10.1038/nature10251 · Cited by 2,697
Multiple sclerosis
Reich, D. S., Lucchinetti, C. F., & Calabresi, P. A. (2018) · New England Journal of Medicine · doi:10.1056/nejmra1401483 · Cited by 2,491
The Immune Epitope Database (IEDB): 2018 update
Vita, R., Mahajan, S., Overton, J. A., Dhanda, S. K., Martini, S. R., Cantrell, J. R., Wheeler, D. K., Sette, A., & Peters, B. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky1006 · Cited by 2,194
Ocrelizumab versus Interferon Beta-1a in Relapsing Multiple Sclerosis
Hauser, S. L., Bar-Or, A., Comi, G., Giovannoni, G., Hartung, H.-P., Hemmer, B., Lublin, F., Montalban, X., Rammohan, K. W., Selmaj, K., et al. (2017) · New England Journal of Medicine · doi:10.1056/nejmoa1601277 · Cited by 2,021
Neurofilaments as biomarkers in neurological disorders
Khalil, M., Teunissen, C. E., Otto, M., Piehl, F., Sormani, M. P., Gattringer, T., Barro, C., Kappos, L., Comabella, M., Fazekas, F., et al. (2018) · Nature Reviews Neurology · doi:10.1038/s41582-018-0058-z · Cited by 1,988
Negative Controls: A Tool for Detecting Confounding and Bias in Observational Studies
Lipsitch, M., Tchetgen Tchetgen, E., & Cohen, T. (2010) · Epidemiology · doi:10.1097/ede.0b013e3181d61eeb · Cited by 1,583
Interactions between genetic, lifestyle and environmental risk factors for multiple sclerosis
Olsson, T. P., Barcellos, L. F., & Alfredsson, L. S. (2016) · Nature Reviews Neurology · doi:10.1038/nrneurol.2016.187 · Cited by 1,263
Serum neurofilament light: a biomarker of neuronal damage in multiple sclerosis
Disanto, G., Barro, C., Benkert, P., Naegelin, Y., Schädelin, S., Giardiello, A., Zecca, C., Blennow, K., Zetterberg, H., Leppert, D., et al. (2017) · Annals of Neurology · doi:10.1002/ana.24954 · Cited by 1,164
Epstein-Barr virus: exploiting the immune system
Thorley‐Lawson, D. A. (2001) · Nature reviews. Immunology · doi:10.1038/35095584 · Cited by 942

Flagged first, then by citations

Show all 51 references

1 of the 51 references couldn’t be matched to a known paper.

Sorted by citations

Items 201–300 of 1,001

High-throughput discovery and characterization of viral transcriptional effectors in human cells
Ludwig, C., Thurm, A. R., Morgens, D. W., Yang, K. J., Tycko, J., Bassik, M. C., Glaunsinger, B. A., & Bintu, L. (2023) · Cell Systems · doi:10.1016/j.cels.2023.05.008 · Cited by 36
TGFβ links EBV to multisystem inflammatory syndrome in children
Goetzke, C. C., Massoud, M., Frischbutter, S., Guerra, G. M., Ferreira‐Gomes, M., Heinrich, F., von Stuckrad, A. S. L., Wisniewski, S., Licha, J. R., Bondareva, M. A., et al. (2025) · Nature · doi:10.1038/s41586-025-08697-6 · Cited by 40
Contribution of B cells to cortical damage in multiple sclerosis
Bhargava, P., Hartung, H.-P., & Calabresi, P. A. (2022) · Brain · doi:10.1093/brain/awac233 · Cited by 36
Targeting NMDA Receptors at the Neurovascular Unit: Past and Future Treatments for Central Nervous System Diseases
Seillier, C., Lesept, F., Toutirais, O., Potzeha, F., Blanc, M., & Vivien, D. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms231810336 · Cited by 47
Tissue specific signature of HHV-6 infection in ME/CFS
Kasimir, F., Toomey, D., Liu, Z., Kaiping, A., Ariza, M. E., & Prusty, B. K. (2022) · Frontiers in Molecular Biosciences · doi:10.3389/fmolb.2022.1044964 · Cited by 36
Multiple Sclerosis Pathogenesis and Updates in Targeted Therapeutic Approaches
Vasileiou, E. S., & Fitzgerald, K. C. (2023) · Current Allergy and Asthma Reports · doi:10.1007/s11882-023-01102-0 · Cited by 41
Assessing clinical utility of machine learning and artificial intelligence approaches to analyze speech recordings in multiple sclerosis: A pilot study
Svoboda, E., Bořil, T., Rusz, J., Tykalová, T., Horáková, D., Guttmann, C. R. G., Blagoev, K. B., Hatabu, H., & Valtchinov, V. I. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105853 · Cited by 39
Is post-COVID syndrome an autoimmune disease?
Anaya, J., Herrán, M., Beltrán, S., & Rojas, M. (2022) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2022.2085561 · Cited by 38
VirScan: High-throughput Profiling of Antiviral Antibody Epitopes
Shrock, E. L., Shrock, C. L., & Elledge, S. J. (2022) · BIO-PROTOCOL · doi:10.21769/bioprotoc.4464 · Cited by 35
Self-citation
Infectious mononucleosis is associated with an increased incidence of multiple sclerosis: Results from a cohort study of 32,116 outpatients in Germany
Loosen, S. H., Doege, C., Meuth, S. G., Luedde, T., Kostev, K., & Roderburg, C. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.937583 · Cited by 34
Establishment of a consensus protocol to explore the brain pathobiome in patients with mild cognitive impairment and Alzheimer's disease
Lathe, R., Schultek, N. M., Balin, B. J., Ehrlich, G. D., Alberi, L. A., Perry, G. L., Breitschwerdt, E. B., Corry, D. B., Doty, R. L., Rissman, R. A., et al. (2023) · Alzheimer s & Dementia · doi:10.1002/alz.13076 · Cited by 39
4D marmoset brain map reveals MRI and molecular signatures for onset of multiple sclerosis–like lesions
Lin, J.-P., Brake, A., Donadieu, M., Lee, A., Smith, G., Hu, K., Nair, G., Kawaguchi, R., Sati, P., Geschwind, D. H., et al. (2025) · Science · doi:10.1126/science.adp6325 · Cited by 35
T-bet+ CXCR3+ B cells drive hyperreactive B-T cell interactions in multiple sclerosis
Jelčić, I., Naghavian, R., Fanaswala, I., Macnair, W., Esposito, C., Calini, D., Han, Y., Marti, Z., Raposo, C., del Castillo, J. S., et al. (2025) · Cell Reports Medicine · doi:10.1016/j.xcrm.2025.102027 · Cited by 42
“4,6,7 Cross-reactivity with the CNS autoantigen RAS guanyl-releasing protein 2 (RASGRP2), expressed by B cells and neuronal cells, 3,4 may contribute to peripheral maintenance of autoreactive T cells, migration to the CNS compartment, and target tissue damage.”
Glymphatics and meningeal lymphatics unlock the brain-immune code
Kim, M. W., & Kipnis, J. (2025) · Immunity · doi:10.1016/j.immuni.2025.03.006 · Cited by 42
EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentation
Wang, J., Qiu, Y., Marti, Z., Li, F., Wacker, M., Oldrati, P., Mühlenbruch, L., Jin, L., Zhang, H., Xu, W., et al. (2026) · Cell · doi:10.1016/j.cell.2025.12.046 · Cited by 52
Role of Dendritic Cells in Viral Brain Infections
Constant, O., Maarifi, G., Blanchet, F. P., Van de Perre, P., Simonin, Y., & Salinas, S. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.862053 · Cited by 35
Biomaterial Strategies for Selective Immune Tolerance: Advances and Gaps
Carey, S. T., Bridgeman, C. J., & Jewell, C. M. (2023) · Advanced Science · doi:10.1002/advs.202205105 · Cited by 34
Rethinking human cytomegalovirus latency reservoir
Schwartz, M., & Stern‐Ginossar, N. (2023) · Annals of the New York Academy of Sciences · doi:10.1111/nyas.14994 · Cited by 35
Learning from the nexus of autoimmunity and cancer
Mangani, D., Yang, D., & Anderson, A. C. (2023) · Immunity · doi:10.1016/j.immuni.2023.01.022 · Cited by 33
Patient iPSC models reveal glia-intrinsic phenotypes in multiple sclerosis
Clayton, B. L. L., Barbar, L., Sapar, M., Kalpana, K., Rao, C., Migliori, B., Rusielewicz, T., Paull, D., Brenner, K., Moroziewicz, D., et al. (2024) · Cell Stem Cell · doi:10.1016/j.stem.2024.08.002 · Cited by 38
Epstein-Barr virus gH/gL has multiple sites of vulnerability for virus neutralization and fusion inhibition
Chen, W., Kim, J., Bu, W., Nathan L. Board, Tsybovsky, Y., Wang, Y., Hostal, A., Andrews, S. F., Gillespie, R. A., Choe, M., et al. (2022) · Immunity · doi:10.1016/j.immuni.2022.10.003 · Cited by 34
Early-life peripheral infections reprogram retinal microglia and aggravate neovascular age-related macular degeneration in later life
Hata, M., Hata, M., Andriessen, E. M. M. A., Juneau, R., Pilon, F., Crespo‐Garcia, S., Diaz-Marin, R., Guber, V., Binet, F., Fournier, F., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci159757 · Cited by 35
The glymphatic system and multiple sclerosis: An evolving connection
Alghanimy, A., Work, L. M., & Holmes, W. M. (2024) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2024.105456 · Cited by 39
Current advancements in cellular immunotherapy for autoimmune disease
Berry, C. T., Frazee, C. P., Herman, P. J., Chen, S., Chen, A., Kuo, Y., & Ellebrecht, C. T. (2025) · Seminars in Immunopathology · doi:10.1007/s00281-024-01034-5 · Cited by 38
A disease-specific convergence of host and Epstein–Barr virus genetics in multiple sclerosis
Mechelli, R., Umeton, R., Bellucci, G., Bigi, R., Rinaldi, V., Angelini, D. F., Guerrera, G., Pignalosa, F. C., Ilari, S., Patrone, M., et al. (2025) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2418783122 · Cited by 36
R9AP is a common receptor for EBV infection in epithelial cells and B cells
Li, Y., Zhang, H., Sun, C., Dong, X.-D., Xie, C., Liu, Y.-T., Lin, R.-B., Kong, X., Hu, Z.-L., Ma, X.-Y., et al. (2025) · Nature · doi:10.1038/s41586-025-09166-w · Cited by 34
EBNA2-EBF1 complexes promote MYC expression and metabolic processes driving S-phase progression of Epstein-Barr virus–infected B cells
Beer, S., Wange, L. E., Zhang, X., Kuklik‐Roos, C., Enard, W., Hammerschmidt, W., Scialdone, A., & Kempkes, B. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2200512119 · Cited by 34
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo
Massimino, L., Palmieri, O., Facoetti, A., Fuggetta, D., Spanò, S., Lamparelli, L. A., D’Alessio, S., Cagliani, S., Furfaro, F., D’Amico, F., et al. (2023) · Gut · doi:10.1136/gutjnl-2022-328375 · Cited by 34
Transgenic expression of the HERV-W envelope protein leads to polarized glial cell populations and a neurodegenerative environment
Gruchot, J., Lewen, I., Dietrich, M., Reiche, L., Sindi, M., Hecker, C., Herrero, F., Charvet, B., Weber‐Stadlbauer, U., Hartung, H., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2308187120 · Cited by 34
Genetics of immune response to Epstein-Barr virus: prospects for multiple sclerosis pathogenesis
Huang, J., Tengvall, K., Lima, I. B., Hedström, A. K., Butt, J., Brenner, N., Gyllenberg, A., Stridh, P., Khademi, M., Ernberg, I. T., et al. (2024) · Brain · doi:10.1093/brain/awae110 · Cited by 33
Long‐term persistence of mitochondrial dysfunctions after viral infections and antiviral therapies: A review of mechanisms involved
Gay, L., Desquiret‐Dumas, V., Nagot, N., Rapenne, C., de Perre, P. V., Reynier, P., & Molès, J. (2024) · Journal of Medical Virology · doi:10.1002/jmv.29886 · Cited by 33
“12,13 This establishes a link between a previous infection and the triggering of autoimmunity or, more generally, a link between communicable and non ‐ communicable diseases.”
Disease-associated oligodendroglia: a putative nexus in neurodegeneration
Castelo‐Branco, G., Kukanja, P., Guerreiro‐Cacais, A. O., & Kirby, L. A. (2024) · Trends in Immunology · doi:10.1016/j.it.2024.08.003 · Cited by 33
Neurological Benefits, Clinical Challenges, and Neuropathologic Promise of Medical Marijuana: A Systematic Review of Cannabinoid Effects in Multiple Sclerosis and Experimental Models of Demyelination
Longoria, V., Parcel, H., Toma, B., Minhas, A., & Zeine, R. R. (2022) · Biomedicines · doi:10.3390/biomedicines10030539 · Cited by 36
Natural Killer Cells in Multiple Sclerosis: Entering the Stage
Beliën, J., Goris, A., & Matthys, P. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.869447 · Cited by 35
Dual Role of B Cells in Multiple Sclerosis
Kumar, G., & Axtell, R. C. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24032336 · Cited by 36
Bystander activated CD8+ T cells mediate neuropathology during viral infection via antigen-independent cytotoxicity
Balint, E., Feng, E., Giles, E. C., Ritchie, T. M., Qian, A. S., Vahedi, F., Montemarano, A., Portillo, A. L., Monteiro, J. K., Trigatti, B. L., et al. (2024) · Nature Communications · doi:10.1038/s41467-023-44667-0 · Cited by 33
“For example, MS has long been suggested to be associated with viral infection, with recent evidence that EBV is the leading cause of the disease 10 .”
Therapeutic vaccines for herpesviruses
Cohen, J. I. (2024) · Journal of Clinical Investigation · doi:10.1172/jci179483 · Cited by 32
Understanding Sex Differences in Autoimmune Diseases: Immunologic Mechanisms
Kim, Y., Jung, Y., Kang, I., & Yeo, E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157101 · Cited by 32
“These pathogens contribute to disease onset and flares by activating innate immunity, inducing IFN-I, recruiting autoreactive lymphocytes, and promoting epitope spreading, molecular mimicry, and bystander activation [214–216].”
T-cell surveillance of the human brain in health and multiple sclerosis
Smolders, J., van Luijn, M. M., Hsiao, C., & Hamann, J. (2022) · Seminars in Immunopathology · doi:10.1007/s00281-022-00926-8 · Cited by 37
B cell targeted therapies in inflammatory autoimmune disease of the central nervous system
Furman, M. J., Meuth, S. G., Albrecht, P., Dietrich, M., Blum, H., Mareš, J., Milo, R., & Hartung, H. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1129906 · Cited by 33
The role of Epstein-Barr virus in autoimmune and autoinflammatory diseases
Borghol, A. H., Bitar, E. R., Hanna, A., Naim, G., & Rahal, E. A. (2024) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2024.2344114 · Cited by 32
“…with eBv only developed MS after their seroconversion. this was proven by demonstrating that biomarkers of neuroaxonal degeneration which is characteristic of MS, such as serum levels of neurofilament light chain, only increased after the subjects became eBv-seropositive (Bjornevik et al. 2022).”
Research landmarks on the 60th anniversary of Epstein-Barr virus
Zhong, L., Xie, C., Zhang, L., Yang, Y.-L., Liu, Y.-T., Zhao, G., Bu, G., Tian, X.-S., Jiang, Z., Yuan, B., et al. (2024) · Science China Life Sciences · doi:10.1007/s11427-024-2766-0 · Cited by 35
“This monumental study solidifies the requirement of EBV infection for the later manifestation of MS (Bjornevik et al., 2022).”
Myasthenia Gravis: An Acquired Interferonopathy?
Payet, C. A., You, A., Fayet, O., Dragin, N., Berrih‐Aknin, S., & Panse, R. L. (2022) · Cells · doi:10.3390/cells11071218 · Cited by 31
Targeting Fibronectin to Overcome Remyelination Failure in Multiple Sclerosis: The Need for Brain- and Lesion-Targeted Drug Delivery
van Schaik, P. E. M., Zuhorn, I. S., & Baron, W. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23158418 · Cited by 35
Synapse Dysfunctions in Multiple Sclerosis
Schwarz, K., & Schmitz, F. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms24021639 · Cited by 36
A unified classification approach rating clinical utility of protein biomarkers across neurologic diseases
Bernhardt, A. M., Tiedt, S., Teupser, D., Dichgans, M., Meyer, B., Gempt, J., Kuhn, P., Simons, M., Palleis, C., Weidinger, E., et al. (2023) · EBioMedicine · doi:10.1016/j.ebiom.2023.104456 · Cited by 32
Inflammation and Epstein–Barr Virus at the Crossroads of Multiple Sclerosis and Post-Acute Sequelae of COVID-19 Infection
Rousseau, B. A., & Bhaduri‐McIntosh, S. (2023) · Viruses · doi:10.3390/v15040949 · Cited by 32
Personalized Use of Disease-Modifying Therapies in Multiple Sclerosis
Lee, C., & Chan, K. (2024) · Pharmaceutics · doi:10.3390/pharmaceutics16010120 · Cited by 32
A cocktail nanovaccine targeting key entry glycoproteins elicits high neutralizing antibody levels against EBV infection
Zhong, L., Zhang, W., Liu, H., Zhang, X., Yang, Z., Wen, Z., Chen, L., Chen, H., Luo, Y., Chen, Y., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-49546-w · Cited by 30
COMBAT ‐ MS : A Population‐Based Observational Cohort Study Addressing the Benefit–Risk Balance of Multiple Sclerosis Therapies Compared with Rituximab
Piehl, F., Alping, P., Virtanen, S., Englund, S., Burman, J., Fink, K., Fogdell‐Hahn, A., Gunnarsson, M., Hillert, J. A., Langer-Gould, A. M., et al. (2024) · Annals of Neurology · doi:10.1002/ana.27012 · Cited by 32
T and B cell responses against Epstein–Barr virus in primary sclerosing cholangitis
ElAbd, H., Pesesky, M. W., Innocenti, G., Chung, B. K., Mahdy, A. K. H., Kriukova, V., Kulsvehagen, L., Strobbe, D., Stühler, C., Gabriele Mayr, B., et al. (2025) · Nature Medicine · doi:10.1038/s41591-025-03692-w · Cited by 30
“…to epidemiological data, we were able to establish a strong association between EBV and PSC. EBV has been implicated previously in multiple autoimmune diseases and immune-mediated inflammatory diseases 43 such as MS 44 , RA 39 , systemic lupus erythematosus (SLE) 45 and Sjögren syndrome 46 .”
Human T-bet+ B cell development is associated with BTK activity and suppressed by evobrutinib
Rijvers, L., van Langelaar, J., Bogers, L., Melief, M., Koetzier, S. C., Blok, K. M., Wierenga‐Wolf, A. F., de Vries, H. E., Rip, J., Corneth, O. B. J., et al. (2022) · JCI Insight · doi:10.1172/jci.insight.160909 · Cited by 30
A case of ANCA-associated vasculitis in a 16-year-old female following SARS-COV-2 infection and a systematic review of the literature
Bryant, M. C., Spencer, L. T., & Yalçindağ, A. (2022) · Pediatric Rheumatology · doi:10.1186/s12969-022-00727-1 · Cited by 30
Melatonin ameliorates disease severity in a mouse model of multiple sclerosis by modulating the kynurenine pathway
Jand, Y., Ghahremani, M. H., Ghanbari, A., Ejtemaei‐Mehr, S., Guillemin, G. J., & Ghazi‐Khansari, M. (2022) · Scientific Reports · doi:10.1038/s41598-022-20164-0 · Cited by 30
A Review of Compartmentalised Inflammation and Tertiary Lymphoid Structures in the Pathophysiology of Multiple Sclerosis
Kee, R., Naughton, M., McDonnell, G. V., Howell, O. W., & Fitzgerald, D. C. (2022) · Biomedicines · doi:10.3390/biomedicines10102604 · Cited by 34
Inhibition of Protein Aggregation and Endoplasmic Reticulum Stress as a Targeted Therapy for α-Synucleinopathy
Siwecka, N., Saramowicz, K., Galita, G., Rozpędek‐Kamińska, W., & Majsterek, I. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15082051 · Cited by 33
The role of microbiomes in gastrointestinal cancers: new insights
Yarahmadi, A., & Afkhami, H. (2024) · Frontiers in Oncology · doi:10.3389/fonc.2023.1344328 · Cited by 30
Neural regeneration in the human central nervous system—from understanding the underlying mechanisms to developing treatments. Where do we stand today?
Kvistad, C. E., Kråkenes, T., Gavasso, S., & Bø, L. (2024) · Frontiers in Neurology · doi:10.3389/fneur.2024.1398089 · Cited by 35
Game of microbes: the battle within – gut microbiota and multiple sclerosis
Turner, T.-A. J., Lehman, P., Ghimire, S., Shahi, S. K., & Mangalam, A. K. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2387794 · Cited by 33
“198,199 However, the role of gut microbiota on pathogenic B cell responses in EBV or MS is poorly understood and requires further study.”
Background
Epstein-Barr Virus in Multiple Sclerosis
Wahbeh, F., & Sabatino, J. J. (2025) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200460 · Cited by 29
“18 Further research into this prodromal period is needed, acknowledging the challenges in acquiring pre-MS samples.”
SARS-CoV-2 and Multiple Sclerosis: Potential for Disease Exacerbation
MacDougall, M., Sleiman, J. E.-H., Beauchemin, P., & Rangachari, M. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.871276 · Cited by 30
Effect of ocrelizumab on leptomeningeal inflammation and humoral response to Epstein-Barr virus in multiple sclerosis. A pilot study
Zivadinov, R., Jakimovski, D., Ramanathan, M. K., Benedict, R. H. B., Bergsland, N., Dwyer, M. G., & Weinstock‐Guttman, B. (2022) · Multiple Sclerosis and Related Disorders · doi:10.1016/j.msard.2022.104094 · Cited by 30
Human herpesvirus 6A and axonal injury before the clinical onset of multiple sclerosis
Grut, V., Biström, M., Salzer, J., Stridh, P., Jons, D., Gustafsson, R. K. L., Fogdell‐Hahn, A., Huang, J., Butt, J., Lindam, A. P., et al. (2023) · Brain · doi:10.1093/brain/awad374 · Cited by 29
Radiologically isolated syndrome in the spectrum of multiple sclerosis
Okuda, D. T., & Lebrun‐Frénay, C. (2024) · Multiple Sclerosis Journal · doi:10.1177/13524585241245306 · Cited by 36
Altered Immune Response to the Epstein–Barr Virus as a Prerequisite for Multiple Sclerosis
Läderach, F., & Münz, C. (2022) · Cells · doi:10.3390/cells11172757 · Cited by 27
The influence of physiological and pathological perturbations on blood-brain barrier function
Zhao, N., Chung, T. D., Guo, Z., Jamieson, J. J., Liang, L. R., Linville, R. M., Pessell, A. F., Wang, L., & Searson, P. C. (2023) · Frontiers in Neuroscience · doi:10.3389/fnins.2023.1289894 · Cited by 31
Viral infections and pathogenesis of glaucoma: a comprehensive review
Ahmad, F., Deshmukh, N., Webel, A. D., Johnson, S., Suleiman, A., Mohan, R. R., Fraunfelder, F. “. W., & Singh, P. K. (2023) · Clinical Microbiology Reviews · doi:10.1128/cmr.00057-23 · Cited by 28
Tertiary lymphoid structures and B-cell infiltration are IPF features with functional consequences
Cocconcelli, E., Balestro, E., Turato, G., Fiorentù, G., Bazzan, E., Biondini, D., Tinè, M., Bernardinello, N., Pezzuto, F., Baraldo, S., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1437767 · Cited by 32
Dental Care and Education Facing Highly Transmissible SARS-CoV-2 Variants: Prospective Biosafety Setting: Prospective, Single-Arm, Single-Center Study
Thurzo, A., Bražinová, A., Markovská, N., Waczulı́ková, I., Smatana, M., Moravanský, N., Urbanová, W., Urban, R., Strunga, M., Kurilová, V., et al. (2022) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph19137693 · Cited by 29
Tissue-resident memory T cells in the multiple sclerosis brain and their relationship to Epstein-Barr virus infected B cells
Serafini, B., Rosicarelli, B., Veroni, C., & Aloisi, F. (2023) · Journal of Neuroimmunology · doi:10.1016/j.jneuroim.2023.578036 · Cited by 28
Treatment Options for Epstein-Barr Virus-Related Disorders of the Central Nervous System
Andersen, O., Ernberg, I. T., & Hedström, A. K. (2023) · Infection and Drug Resistance · doi:10.2147/idr.s375624 · Cited by 28
Postinfectious Inflammation, Autoimmunity, and Obsessive-Compulsive Disorder: Sydenham Chorea, Pediatric Autoimmune Neuropsychiatric Disorder Associated with Streptococcal Infection, and Pediatric Acute-Onset Neuropsychiatric Disorder
Vreeland, A., Calaprice, D., Or‐Geva, N., Frye, R. E., Agalliu, D., Lachman, H. M., Pittenger, C., Pallanti, S., Williams, K., Ma, M., et al. (2023) · Developmental Neuroscience · doi:10.1159/000534261 · Cited by 28
Epstein-Barr virus gp42 antibodies reveal sites of vulnerability for receptor binding and fusion to B cells
Bu, W., Kumar, A., Nathan L. Board, Kim, J., Dowdell, K., Zhang, S., Lei, Y., Hostal, A., Krogmann, T. A., Wang, Y., et al. (2024) · Immunity · doi:10.1016/j.immuni.2024.02.008 · Cited by 28
Deleterious functional consequences of perfluoroalkyl substances accumulation into the myelin sheath
Butruille, L., Jubin, P., Martin, E., Aigrot, M., Lhomme, M., Fini, J., DEMENEIX, B. A., Stankoff, B., Lubetzki, C., Zalc, B., et al. (2023) · Environment International · doi:10.1016/j.envint.2023.108211 · Cited by 28
Epstein–Barr Virus Strongly Associates With Pediatric Multiple Sclerosis, But Not Myelin Oligodendrocyte Glycoprotein‐Antibody‐Associated Disease
Fadda, G., Yea, C., O’Mahony, J., Waters, P. J., Yeh, E. A., Marrie, R. A., Arnold, D. L., Bar‐Or, A., Banwell, B., & the Canadian Pediatric Demyelinating Disease Study Group (2024) · Annals of Neurology · doi:10.1002/ana.26890 · Cited by 29
“Nonetheless, current evidence supports the view of EBV infection preceding the biological onset of MS in adults, 5 and we postulate a similar direction of causality in the pediatric population.”
Multisensory gamma stimulation mitigates the effects of demyelination induced by cuprizone in male mice
Rodrígues-Amorím, D., Bozzelli, P. L., Kim, T., Liu, L., Gibson, O., Yang, C.-Y., Murdock, M. H., Galiana-Melendez, F., Schatz, B., Davison, A., et al. (2024) · Nature Communications · doi:10.1038/s41467-024-51003-7 · Cited by 32
“Recently, environmental factors, such as Epstein-Bar virus infection have been associated with multiple sclerosis 42 .”
Transgenerational epigenetic inheritance: a critical perspective
Bird, A. P. (2024) · Frontiers in Epigenetics and Epigenomics · doi:10.3389/freae.2024.1434253 · Cited by 32
“In a notable recent case, longitudinal studies on an unprecedented scale provided a compelling causal link between the relatively common disorder multiple sclerosis and infection by Epstein-Barr virus (Bjornevik et al., 2022).”
Exploring the Pathophysiology, Diagnosis, and Treatment Options of Multiple Sclerosis
Lorenzut, S., Negro, I. D., Pauletto, G., Verriello, L., Spadea, L., Salati, C., Musa, M., Gagliano, C., & Zeppieri, M. (2025) · Journal of Integrative Neuroscience · doi:10.31083/jin25081 · Cited by 36
SP140–RESIST pathway regulates interferon mRNA stability and antiviral immunity
Witt, K. C., Dziulko, A., An, J., Pekovic, F., Cheng, A. X., Liu, G. Y., Lee, O. V., Turner, D. J., Lari, A., Gaidt, M. M., et al. (2025) · Nature · doi:10.1038/s41586-025-09152-2 · Cited by 30
Ponesimod in the Treatment of Relapsing Forms of Multiple Sclerosis: An Update on the Emerging Clinical Data
Ruggieri, S., Quartuccio, M. E., & Prosperini, L. (2022) · Degenerative Neurological and Neuromuscular Disease · doi:10.2147/dnnd.s313825 · Cited by 29
Guilty by association: Epstein–Barr virus in multiple sclerosis
Bar‐Or, A., Banwell, B., Berger, J. R., & Lieberman, P. M. (2022) · Nature Medicine · doi:10.1038/s41591-022-01823-1 · Cited by 27
IFI16 Partners with KAP1 to Maintain Epstein-Barr Virus Latency
Xu, H., Li, X., Rousseau, B. A., Akinyemi, I. A., Frey, T. R., Zhou, K., Droske, L. E., Mitchell, J. A., McIntosh, M. T., & Bhaduri‐McIntosh, S. (2022) · Journal of Virology · doi:10.1128/jvi.01028-22 · Cited by 28
Evolution of functional antibodies following acute Epstein-Barr virus infection
Karsten, C. B., Bartsch, Y. C., Shin, S. A., Slein, M. D., Heller, H. M., Kolandaivelu, K., Middeldorp, J. M., Alter, G., & Jülg, B. D. (2022) · PLoS Pathogens · doi:10.1371/journal.ppat.1010738 · Cited by 27
Siblings reduce multiple sclerosis risk by preventing delayed primary Epstein–Barr virus infection
Rostgaard, K., Nielsen, N. M., Melbye, M., Frisch, M., & Hjalgrim, H. (2022) · Brain · doi:10.1093/brain/awac401 · Cited by 27
Immunopathogenesis, Diagnosis, and Treatment of Multiple Sclerosis
Pérez, C. A., Cuascut, F. X., & Hutton, G. J. (2022) · Neurologic Clinics · doi:10.1016/j.ncl.2022.05.004 · Cited by 33
Antigenic mimicry – The key to autoimmunity in immune privileged organs
Wildner, G. (2022) · Journal of Autoimmunity · doi:10.1016/j.jaut.2022.102942 · Cited by 32
A common mechanism links Epstein‐Barr virus infections and autoimmune diseases
Zhang, L. (2022) · Journal of Medical Virology · doi:10.1002/jmv.28363 · Cited by 27
EBNA1 Inhibitors Block Proliferation of Spontaneous Lymphoblastoid Cell Lines From Patients With Multiple Sclerosis and Healthy Controls
Monaco, M. C., Soldan, S. S., Su, C., Clauze, A., Cooper, J. F., Patel, R. J., Lu, F., Hughes, R. J., Messick, T. E., Andrada, F. C., et al. (2023) · Neurology Neuroimmunology & Neuroinflammation · doi:10.1212/nxi.0000000000200149 · Cited by 28
Epstein-Barr virus infection as potential indicator of the occurrence and clinical presentation of systemic lupus erythematosus
Banko, A. V., Cirkovic, A. M., Mišković, R., Jeremić, I., Grk, M., Basaric, M., Lazarević, I., Rašković, S., Despotović, A., & Miljanovic, D. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1307589 · Cited by 27
LMP1 and EBNA2 constitute a minimal set of EBV genes for transformation of human B cells
Zhang, J., Sommermann, T. G., Li, X., Gieselmann, L., de la Rosa, K., Stecklum, M., Klein, F., Kocks, C., & Rajewsky, K. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1331730 · Cited by 27
Contribution of CNS and extra-CNS infections to neurodegeneration: a narrative review
Kettunen, P., Koıstınaho, J., & Rõlova, T. (2024) · Journal of Neuroinflammation · doi:10.1186/s12974-024-03139-y · Cited by 30
“Up to 32-fold increase in MS risk has been reported following EBV infection [8, 134, 135].”
Background
A single-cell compendium of human cerebrospinal fluid identifies disease-associated immune cell populations
Cantoni, C., Smirnov, R. A., Firulyova, M. M., Andhey, P. S., Bradstreet, T. R., Esaulova, E., Terekhova, M., Schwarzkopf, E. A., Abdalla, N. M., Kleverov, M., et al. (2025) · Journal of Clinical Investigation · doi:10.1172/jci177793 · Cited by 26
“It is intriguing to consider whether EBV, postulated to be required for the development of MS (65), may have a role in triggering an atypical memory B cell signature, or alternatively whether these cells may facilitate EBV persistence or reactivation.”
Autoimmunity in long COVID
Talwar, S., Harker, J. A., Openshaw, P., & Thwaites, R. S. (2025) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2025.02.005 · Cited by 34
Sphingolipid Players in Multiple Sclerosis: Their Influence on the Initiation and Course of the Disease
Podbielska, M., Ariga, T., & Pokryszko‐Dragan, A. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105330 · Cited by 29
Serum MOG-IgG in children meeting multiple sclerosis diagnostic criteria
Fadda, G., Waters, P. J., Woodhall, M. R., Brown, R. A., O’Mahony, J., Castro, D. A., Longoni, G., Yeh, E. A., Marrie, R. A., Arnold, D. L., et al. (2022) · Multiple Sclerosis Journal · doi:10.1177/13524585221093789 · Cited by 26
At the Root of 3 “Long” Diseases: Persistent Antigens Inflicting Chronic Damage on the Brain and Other Organs in Gulf War Illness, Long-COVID-19, and Chronic Fatigue Syndrome
James, L. M., & Georgopoulos, A. P. (2022) · Neuroscience Insights · doi:10.1177/26331055221114817 · Cited by 27
Proteomic Profiling of Hypoplastic Lungs Suggests an Underlying Inflammatory Response in the Pathogenesis of Abnormal Lung Development in Congenital Diaphragmatic Hernia
Wagner, R., Lieckfeldt, P., Piyadasa, H., Markel, M., Riedel, J., Stefanovici, C., Peukert, N., Patel, D., Derraugh, G., Min, S. A. L., et al. (2022) · Annals of Surgery · doi:10.1097/sla.0000000000005656 · Cited by 25
Are Viral Infections Key Inducers of Autoimmune Diseases? Focus on Epstein–Barr Virus
Takei, M., Kitamura, N., Nagasawa, Y., Tsuzuki, H., Iwata, M., Nagatsuka, Y., Nakamura, H., Imai, K., & Fujiwara, S. (2022) · Viruses · doi:10.3390/v14091900 · Cited by 26
Validity of serum neurofilament light chain as a prognostic biomarker of disease activity in multiple sclerosis
Sen, M. K., Hossain, M. J., Mahns, D. A., & Brew, B. J. (2022) · Journal of Neurology · doi:10.1007/s00415-022-11507-y · Cited by 29
The Contribution of Microglia and Brain-Infiltrating Macrophages to the Pathogenesis of Neuroinflammatory and Neurodegenerative Diseases during TMEV Infection of the Central Nervous System
DePaula-Silva, A. B. (2024) · Viruses · doi:10.3390/v16010119 · Cited by 29
“…the di ﬀ erent roles played macrophages in each mouse model, focusing on its contribution to disease closely associated with the development of neuroin ﬂ ammatory and neurodegenerative diseases such as multiple sclerosis (MS) [6–11], Alzheimer’s [10,12,13], epilepsy [14–25], and others [26–30].”
BackgroundInfluential

Authors: Bjornevik, K., Cortese, M., Healy, B. C., Kuhle, J., Mina, M. J., Leng, Y., Elledge, S. J., Niebuhr, D. W., Scher, A. I., Munger, K. L., & Ascherio, A.
Affiliations: Department of Nutrition, Harvard T. H. Chan School of Public Health, Boston, MA, USA.
Harvard University (US)
Brigham and Women's Hospital (US)
Neurologic Clinic and Policlinic, MS Center and Research Center for Clinical Neuroimmunology and Neuroscience Basel (RC2NB), University Hospital Basel, University of Basel, Basel, Switzerland.
Uniformed Services University of the Health Sciences (US)
Department of Preventive Medicine and Biostatistics, Uniformed Services University of the Health Sciences, Bethesda, MD, USA.
Corresponding author: Cortese, Marianna
Munger, Kassandra L.
Ascherio, Alberto
ORCID: Bjornevik, Kjetil
Cortese, Marianna
Healy, Brian C.
Mina, Michael J.
Leng, Yumei
Elledge, Stephen J.
Munger, Kassandra L.
Ascherio, Alberto
Venue: Science
Publisher: American Association for the Advancement of Science (AAAS)
Published: 2022-01-21
Volume: 375
Issue: 6578
Pages: 296-301
ISSN: 0036-8075 (ISSN-L)
1095-9203
DOI: 10.1126/science.abj8222
OpenAlex: W4205972999
Cited by: 2,049
References: 51
Citations by year: 2026: 354 · 2025: 412 · 2024: 461 · 2023: 432 · 2022: 388
FWCI: 289.56
Type: journal article
Language: en
Open access: closed
Locations: Science (publishedVersion)
PubMed (publishedVersion)
Funders: Howard Hughes Medical Institute
National Institute of Neurological Disorders and Stroke (R01NS042194, R01NS046635, R01NS103891)
Topics: Health Sciences › Medicine › Clinical Neurology › Multiple Sclerosis Research Studies
Health Sciences › Medicine › Oncology › Viral-associated cancers and disorders
Health Sciences › Medicine › Epidemiology › Cytomegalovirus and herpesvirus research
Keywords: multiple sclerosis, Epstein-Barr virus, viral etiology, neurofilament light chain, neuroaxonal degeneration, cytomegalovirus, demyelinating disease, military personnel
MeSH terms: Antibodies, Viral, Cytomegalovirus, Herpesvirus 4, Human, Female, Humans, Longitudinal Studies, Male, Military Personnel, Multiple Sclerosis, Risk Factors, Cohort Studies, Biomarkers, Prevalence, Neurofilament Proteins, Age of Onset, Epstein-Barr Virus Infections, Young Adult

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosis

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks